Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Volume 48, Issue 3, Pages 407-415
Publisher
Oxford University Press (OUP)
Online
2015-01-22
DOI
10.1093/ejcts/ezu539
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The biomarker plasma galectin-3 in advanced heart failure and survival with mechanical circulatory support devices
- (2013) Gülsüm Erkilet et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension
- (2012) Mark Rosenberg et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Functional and haemodynamic recovery after implantation of continuous-flow left ventricular assist devices in comparison with pulsatile left ventricular assist devices in patients with end-stage heart failure
- (2012) Ralph V. Pruijsten et al. EUROPEAN JOURNAL OF HEART FAILURE
- Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support
- (2012) Sjoukje I. Lok et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling
- (2011) Tomoko S. Kato et al. Circulation-Heart Failure
- Reverse Remodeling With Left Ventricular Assist Devices
- (2011) Amrut V. Ambardekar et al. Circulation-Heart Failure
- Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin αVβ3 engagement and PI3K/pAkt/NFκB signaling
- (2011) Raquel Urtasun et al. HEPATOLOGY
- Osteopontin: A potential biomarker for heart failure and reverse remodeling after left ventricular assist device support
- (2011) Marguérite E.I. Schipper et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
- (2010) Ravi V. Shah et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist
- (2010) Shunsuke Saito et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Impact of Mechanical Unloading on Microvasculature and Associated Central Remodeling Features of the Failing Human Heart
- (2010) Stavros G. Drakos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Criteria for Evaluation of Novel Markers of Cardiovascular Risk
- (2009) Mark A. Hlatky et al. CIRCULATION
- Expression of Extracellular Matrix Genes During Myocardial Recovery From Heart Failure After Left Ventricular Assist Device Support
- (2009) Leanne E. Felkin et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
- (2009) Mark S. Slaughter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Connective tissue growth factor and cardiac fibrosis
- (2008) A. Daniels et al. Acta Physiologica
- Osteopontin, a New Prognostic Biomarker in Patients With Chronic Heart Failure
- (2008) Mark Rosenberg et al. Circulation-Heart Failure
- Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices
- (2008) Hendrik Milting et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started